Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,756.50
Bid: 1,756.50
Ask: 1,757.00
Change: 0.50 (0.03%)
Spread: 0.50 (0.028%)
Open: 1,743.50
High: 1,758.50
Low: 1,740.50
Prev. Close: 1,756.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London pre-open: FTSE to open marginally higher

Tue, 12th Nov 2013 06:59

City sources predict the FTSE 100 will open around two points higher than yesterday's close of 6,728.37, tracking modest gains seen in the US last night and ahead of today's inflation figures.US markets ended slightly higher yesterday, with the Dow Jones Industrial Average hitting another record close, extending recent gains despite increased speculation surrounding the impending taper of quantitative easing.Today, all eyes will turn to German and UK inflation. Germany's consumer price index (CPI) is expected to remain unchanged at 1.2% in October. UK inflation is predicted to fall to 2.5% in October from 2.7% a month earlier. It will come a day ahead of the Bank of England's quarterly inflation report which will be watched closely to see if the central bank upgrades its economic forecasts. A change in economic projections could set the stage for bringing forward the expected date of its first interest rate hike.In other news, Energy Secretary Ed Davey is today expected to say that energy customers are not "cash cows" that can be "squeezed" to earn higher profits for shareholders. The Liberal Democrat Minister is set to urge businesses in the industry to become more transparent about exactly how they are tackling rising bills. CRH delivers modest Q3 rise in sales In this morning's company news, building materials giant CRH reported a small increase in like-for-like (LFL) sales in the third quarter, a strong turnaround after difficult weather conditions hit revenues in the first half. LFL sales in the three months to the end of September improved by 2% across the group, following a 6% decline in the first six months of the year. Overall sales revenue totalled €5.4bn during the period, some 2% ahead of the €5.3bn reported the year before.Babcock International Group has lifted its dividend by 10% to 6.9p due to a strong first half and a positive outlook. The engineering support services company achieved pre-tax profit of £105.9m in the six months through September, up 32% on the previous year's £80.4m.Real estate giant Land Securities posted improved revenue profit and net asset value (NAV) during the six months ended September 30th and said it is confident of delivering future progress. The UK's largest commercial property firm said basic NAV per share rose to 994p in the period from 959p a year earlier. Revenue profit rose to 8.9% to £156.5m.GlaxoSmithKline's heart disease drug, darapladib, has missed a key milestone in its development. The group said it would continued to investigate the darapladib inhibitor and would work to better understand the data, including evaluation of the patient sub-groups, and await the outcome of a second Phase III study of darapladib in acute coronary syndrome to help it determine its next stage of work. Monday's big moversYesterday, in a major blow to BSkyB and ITV, telecoms group BT confirmed that it has won the exclusive rights to broadcast live the UEFA Champions League and UEFA Europa League for three seasons. RSA Insurance was also a heavy faller after saying that "issues in the Irish claims and finance functions" were found during a routine internal audit, leading to the suspension of its Ireland Chief Executive Officer (CEO) and two of his senior executives. NR
More News
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.